GW Pharma CEO: It’s ‘important to distinguish between what’s medicine and what’s not’ in cannabis

Jim Cramer hears from GW Pharmaceuticals CEO Justin Gover about his company’s cannabis-based epilepsy treatment that just launched in the United States.

Main Source
Author:

You might also like More from author

Comments are closed.